Clue, a Berlin-based femtech company, announced today that it has received FDA clearance to launch Clue Birth Control, an all-digital form of contraceptive that relies on period tracking data.
By combining user menstrual cycle data with Clue’s predictive algorithm, the birth control feature can show which days are high or low risk for pregnancy. From there, users can modify their behaviors to...
